|
Fig. 1 Effect of fluoxetine on zebrafish embryonic development: (A) Accumulative survival (%) (n = 800); (B) Hatched embryos (%) (n = 300–340); (C) Malformations at 168 hpf (%) (n = 760–765; (D) No swimming bladder inflation at 168 hpf (%) (n = 550–560); (E) Zebrafish larvae length (n = 105); (F) Zebrafish larvae cardiac activity (n = 65–70). All data are reported as mean values ± standard error. Different letters indicate statistical different subset groups following either Kruskal-Wallis test with Dunn's multiple comparison test (Cumulative survival (%), zebrafish larvae length and cardiac activity) or one-way ANOVA with Tukey post hoc (Hatched embryos (%)). The data of accumulative observed malformations and delayed swimming bladder inflation were analyzed using the chi-square test.